Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced an expanded strategic collaboration with a leading US-based biopharmaceutical company. The expansion adds two biologics programs to be produced commercially, with the option for two more, and further strengthens an estab…
Merck, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, entered into a definitive agreement pursuant to which Merck will, subject to customary closing conditions, acquire Bio-Techne for US$73 per s…
Antares Therapeutics, Inc., a biotechnology company developing first-in-class precision medicines for cancer and other serious diseases, announced a strategic collaboration with Novartis to discover, develop and commercialize small molecule therapies against promising but historically undruggable oncology targets. The…
Agilent Technologies Inc. announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life S…
Abbisko Therapeutics Co., Ltd. announced that it has entered into a strategic research collaboration and license agreement with Eli Lilly and Company, a leading global pharmaceutical company. Under the agreement, the two companies will collaborate on the discovery and development of innovative medicines across multipl…
Evonik is selling selected production assets for pharmaceutical ingredients in Hanau, Germany to the contract manufacturer ProChem Group. By acquiring the facilities, the ProChem Group will strengthen its production capabilities, enhance its technological expertise, and expand its services to pharmaceutical customers.…
AbbVie and Apogee Therapeutics announced they have entered into a definitive agreement under which AbbVie will acquire Apogee and its diverse pipeline of multiple clinical-stage candidates in development across inflammatory and immunological diseases, including atopic dermatitis (AD) and asthma. The acquisition comple…
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines leader, have signed an Memorandum of Understanding and intend to into an agreement to advance their partnership in vaccine innovation and to jointly explore the development of…
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collabor…
Roche announced that it has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics, Inc. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialise bexobrutideg (NX-5948), Nurix’s investigational Bruton’s Tyrosine Kinase (BTK) degrader. The…
Page 8 of 40